Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | RECQL | P46063 | 3/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.38 |
| ▸ | F7 | P08709 | 5/20 | 0.38 |
| ▸ | F3 | P13726 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.38 |
| ▸ | PPARG | P37231 | 3/20 | 0.38 |
| ▸ | PPARD | Q03181 | 3/20 | 0.38 |
| ▸ | PPARA | Q07869 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6568190 | 1.00 | SOAT1 (0.40) | SOAT1CYP3A4LMNAMAPTRECQL | |
| SCHEMBL6568193 | 1.00 | SOAT1 (0.40) | SOAT1CYP3A4LMNAMAPTRECQL | |
| SCHEMBL31019570 | 1.00 | SOAT1 (0.40) | SOAT1CYP3A4LMNAMAPTRECQL | |
| SCHEMBL5530196 | 1.00 | SOAT1 (0.40) | SOAT1CYP3A4LMNAMAPTRECQL | |
| SCHEMBL20503587 | 1.00 | SOAT1 (0.40) | SOAT1CYP3A4LMNAMAPTRECQL | |
| SCHEMBL31703821 | 1.00 | SOAT1 (0.40) | SOAT1CYP3A4LMNAMAPTRECQL | |
| SCHEMBL3194497 | 0.94 | SOAT1 (0.34) | SOAT1CYP3A4LMNAMAPTRECQL | |
| SCHEMBL17674565 | 0.90 | PPARG (0.33) | ALDH1A1ALOX15PPARGPPARDPPARA | |
| SCHEMBL27133071 | 0.89 | SOAT1 (0.49) | SOAT1CYP3A4LMNAMAPTRECQL | |
| SCHEMBL29196128 | 0.87 | SOAT1 (0.51) | SOAT1CYP3A4LMNAMAPTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021123128-A1 | YEAST CELLS AND METHODS FOR PRODUCTION OF E8,E10-DODECADIENYL COENZYME A, CODLEMONE AND DERIVATIVES THEREOF | BIOPHERO APS (DK) | 2021-06-24 | — | — | WO | claimed |
| WO-2021078452-A1 | IMPROVED METHODS FOR PRODUCTION, RECOVERY AND SECRETION OF HYDROPHOBIC COMPOUNDS IN A FERMENTATION | BIOPHERO APS (DK) | 2021-04-29 | — | — | WO | claimed |
| US-6395775-B1 | Combating pest insects | LOEFQVIST JAN (SE) | 2002-05-28 | — | — | US | claimed |
| CN-108688118-B | Method for producing a polymer tube filled with liquid and sealed at fixed intervals and device for producing said polymer tube | 信越化学工业株式会社 | 2021-12-14 | — | — | CN | disclosed |
| WO-2021123128-A1 | YEAST CELLS AND METHODS FOR PRODUCTION OF E8,E10-DODECADIENYL COENZYME A, CODLEMONE AND DERIVATIVES THEREOF | BIOPHERO APS (DK) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021078452-A1 | IMPROVED METHODS FOR PRODUCTION, RECOVERY AND SECRETION OF HYDROPHOBIC COMPOUNDS IN A FERMENTATION | BIOPHERO APS (DK) | 2021-04-29 | — | — | WO | disclosed |
| CN-111212883-A | Volatile material emitting composition | 住友精化株式会社 | 2020-05-29 | — | — | CN | disclosed |
| US-20140311015-A1 | INSECT TRAP HAVING A DESIGN THAT RESEMBLES A BIOLOGICAL DESIGN | ChemTica Internacional (CR) | 2014-10-23 | — | — | US | disclosed |
| US-20130111802-A1 | SELF-OPENING INSECT TRAP AND LURE | OEHLSCHLAGER ALLAN CAMERON (CR) | 2013-05-09 | — | — | US | disclosed |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2007-02-22 | — | — | US | disclosed |
| US-6395775-B1 | Combating pest insects | LOEFQVIST JAN (SE) | 2002-05-28 | — | — | US | disclosed |
| US-6165500-A | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2000-12-26 | — | — | US | disclosed |
| US-5708168-A | FOR TREATING OR PREVENTING NEURONAL LOSS | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) | 1998-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | FABP4, NPC1L1, LIPA | SOAT1 200/4885CYP3A4 2867/4885LMNA 327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.